• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 12 Mar 2024

BQE: Profitable & Growing Micro-Cap in the Water Treatment Industry


BQE Water Inc (BQE:TSX) | 0 0 0.0%


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 29 pages


 

What you need to know: • BQE’s recurring revenue is growing as a percentage of total revenue, making its business more predictable and stable. • The Company has major tailwinds from increasing environmental regulations on water discharge as well as increasing mining capex. • BQE’s EBITDA margins have been steadily improving over the past five years due to its asset-light model, reaching 22% in 2023E. • BQE trades at 5.5x 2025E EBITDA, a significant discount to its peers. BQE Water (BQE:TSXV, BTQNF:OTC) is a leading provider of water treatment services for mining and metallurgical processing clients globally. BQE uses innovative solutions and a holistic approach to water management throughout the project life cycle to drive regulatory compliance and social responsibility. Over the past five years, BQE has grown proportional revenue (including its share of JV revenue) at a 17% CAGR and adjusted EBITDA at a 32% CAGR; We believe it can sustain these growth rates while recurring revenue becomes a larger portion of its business and ESG tailwinds support demand. We are initiating coverage on BQE Water with a BUY rating and target price of $55.00/share. Investment Thesis Summary Growing Stream of Recurring Revenue. Recurring revenue represents over 30% of BQE’s proportional revenue through the production of clean water and tolling fees from various long-term contracts. This figure has increased from 13% in 2020 as BQE’s clients advance their projects into production; we expect recurring revenue to represent 44% of proportional revenue by 2025. Tailwinds in Environmental Regulations & Mining Capex. Environmental regulations for water discharge have been getting increasingly strict over the years. Additionally, we believe we are in the early innings of a mining capex cycle where hundreds of new mines will be opened, playing into BQE’s value proposition. Highly Profitable & Improving. BQE has been steadily increasing its EBITDA margins from negative levels a decade ago to 22% in 2023E. BQE’s business model is asset-light as its clients pay for the capex required for the water management plants. As such, we expect profitability to continue scaling upward with size. Unique IP Protects & Drives Growth. BQE has unique IP in areas of crucial importance for miners to meet regulations and/or reduce costs and risks. Regulations drive the demand for BQE’s IP in selenium, sulphate, ammonia, thiosalts, cyanide, and trace heavy metals removal. Clean Balance Sheet & Capital Structure. BQE has an excellent balance sheet, with $6.7M in cash (and growing) and no interest-bearing debt. Its capital structure is incredibly tight with only 1.3M shares, having not raised equity since 2018. 46% of BQE’s stock is held by three private investors and 8% by management/board. Value Stock in a High Multiple Industry. BQE trades at 6.4x/5.5x 2024E/2025E EBITDA compared to engineering service firms at 14.1x/12.8x and water treatment firms at 11.5x/10.3x. Furthermore, there have been several acquisitions in the water treatment space over the last few years, which average 15x trailing EBITDA. We value BQE using 9.0x 2025E EBITDA, translating to our $55.00/share target.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

BQE: Profitable & Growing Micro-Cap in the Water Treatment Industry


BQE Water Inc (BQE:TSX) | 0 0 0.0%


  • Published: 12 Mar 2024
  • Author: Nicholas Cortellucci, CFA
  • Pages: 29
  • Atrium Research


What you need to know: • BQE’s recurring revenue is growing as a percentage of total revenue, making its business more predictable and stable. • The Company has major tailwinds from increasing environmental regulations on water discharge as well as increasing mining capex. • BQE’s EBITDA margins have been steadily improving over the past five years due to its asset-light model, reaching 22% in 2023E. • BQE trades at 5.5x 2025E EBITDA, a significant discount to its peers. BQE Water (BQE:TSXV, BTQNF:OTC) is a leading provider of water treatment services for mining and metallurgical processing clients globally. BQE uses innovative solutions and a holistic approach to water management throughout the project life cycle to drive regulatory compliance and social responsibility. Over the past five years, BQE has grown proportional revenue (including its share of JV revenue) at a 17% CAGR and adjusted EBITDA at a 32% CAGR; We believe it can sustain these growth rates while recurring revenue becomes a larger portion of its business and ESG tailwinds support demand. We are initiating coverage on BQE Water with a BUY rating and target price of $55.00/share. Investment Thesis Summary Growing Stream of Recurring Revenue. Recurring revenue represents over 30% of BQE’s proportional revenue through the production of clean water and tolling fees from various long-term contracts. This figure has increased from 13% in 2020 as BQE’s clients advance their projects into production; we expect recurring revenue to represent 44% of proportional revenue by 2025. Tailwinds in Environmental Regulations & Mining Capex. Environmental regulations for water discharge have been getting increasingly strict over the years. Additionally, we believe we are in the early innings of a mining capex cycle where hundreds of new mines will be opened, playing into BQE’s value proposition. Highly Profitable & Improving. BQE has been steadily increasing its EBITDA margins from negative levels a decade ago to 22% in 2023E. BQE’s business model is asset-light as its clients pay for the capex required for the water management plants. As such, we expect profitability to continue scaling upward with size. Unique IP Protects & Drives Growth. BQE has unique IP in areas of crucial importance for miners to meet regulations and/or reduce costs and risks. Regulations drive the demand for BQE’s IP in selenium, sulphate, ammonia, thiosalts, cyanide, and trace heavy metals removal. Clean Balance Sheet & Capital Structure. BQE has an excellent balance sheet, with $6.7M in cash (and growing) and no interest-bearing debt. Its capital structure is incredibly tight with only 1.3M shares, having not raised equity since 2018. 46% of BQE’s stock is held by three private investors and 8% by management/board. Value Stock in a High Multiple Industry. BQE trades at 6.4x/5.5x 2024E/2025E EBITDA compared to engineering service firms at 14.1x/12.8x and water treatment firms at 11.5x/10.3x. Furthermore, there have been several acquisitions in the water treatment space over the last few years, which average 15x trailing EBITDA. We value BQE using 9.0x 2025E EBITDA, translating to our $55.00/share target.

More Content

More Content

BQE: Monster Q1 Beat on Technical Services Outperformance

Companies: BQE Water Inc

Atrium Research

BQE: Q4 Financials Preview

Companies: BQE Water Inc

Atrium Research

BQE: Wrapping Up Another Record Year

Companies: BQE Water Inc

Atrium Research

BQE: Excellent Q4 Financials; Increasing Target Price

Companies: BQE Water Inc

Atrium Research

Q1/25 Recap: All Our Research in One Place!

Companies: NIM SCZ DRX AUAU ARG OMG BQE DNG EDG KNR MOO NIM RIO SBIO LVG TOC TM SCZ CAPT GIGA APM FISH

Atrium Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In